Announcements Trials
Browse Landscape

Phase

Phase 2 79Phase 1/2 17Phase 3 11Phase NA 6Phase 1 6Phase 4 4Phase 2/3 2Phase EARLY_PHASE1 1

Status

Recruiting 3Not yet recruiting 2Unknown 1

Sponsor Class

OTHER 5OTHER_GOV 1

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 5Genitourinary 1

Conditions

Colorectal Neoplasms 3Stomach Neoplasms 1MSS Metastatic Colorectal Cancer 1Carcinoma, Renal Cell 1

Interventions

Exercise 439Blood Specimen Collection 333Standard of Care 321Magnetic Resonance Spectroscopy 258Radiotherapy 255Surveys and Questionnaires 245Radiosurgery 245Educational Status 230Methods 229Early Intervention, Educational 218Practice Guidelines as Topic 146Interviews as Topic 146Biopsy 145Surgical Procedures, Operative 134Drug Therapy 133Control Groups 128Acupuncture Therapy 124Therapeutics 110Cyclophosphamide 103Palliative Care 101Counseling 101Resistance Training 95Saline Solution 90Cisplatin 90Magnetic Resonance Imaging 89Radiofrequency Ablation 86Radiotherapy, Intensity-Modulated 79Colonoscopy 79Specimen Handling 78Cognitive Behavioral Therapy 72

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase NA × Interventional × HMPL-013 × Clear all
NCT07124858 2026-05-26

COFRUQ

Federation Francophone de Cancerologie Digestive

Phase NA Recruiting
300 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT07552402 2026-04-27

FREEDOM

Harbin Medical University

Phase NA Not yet recruiting
150 enrolled
Gastrointestinal

Stomach Neoplasms

NCT06985316 2025-05-22

An Exploratory Clinical Study Evaluating the Efficacy and Safety of Tunlametinib Combined With Fruquintinib in the Third-line Treatment of Advanced Colorectal Cancer Patients With RAS Mutations.

Tongji Hospital

Phase NA Not yet recruiting
34 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT06613113 2024-09-25

Fruquintinib Combined With Adebrelimab and High and Low Dose Radiotherapy in the Treatment of Second-line and Above Failure MSS Metastatic Colorectal Cancer.

Ningbo Medical Center Lihuili Hospital

Phase NA Recruiting
30 enrolled
Gastrointestinal

MSS Metastatic Colorectal Cancer

NCT06551207 2024-08-13

Cadonilimab Combined With Fruquintinib and SBRT as Athird-line and Posterior Line Treatment in Patients With MSS CRC

Tongji Hospital

Phase NA Recruiting
80 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT06317298 2024-03-19

Fruquintinib Plus Everolimus as 2nd Line Therapy of ccRCC Patients Progressed Post IO and TKI Therapy

Peking University First Hospital

Phase NA Unknown
36 enrolled
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡